Susceptibility of human immunodeficiency virus type 1 to the maturation inhibitor bevirimat is modulated by baseline polymorphisms in Gag spacer peptide 1 (Q42202820)
Jump to navigation
Jump to search
scientific article published on 17 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Susceptibility of human immunodeficiency virus type 1 to the maturation inhibitor bevirimat is modulated by baseline polymorphisms in Gag spacer peptide 1 |
scientific article published on 17 February 2009 |
Statements
1 reference
Susceptibility of human immunodeficiency virus type 1 to the maturation inhibitor bevirimat is modulated by baseline polymorphisms in Gag spacer peptide 1 (English)
1 reference
Kurt Van Baelen
1 reference
Karl Salzwedel
1 reference
Evelien Rondelez
1 reference
Veerle Van Eygen
1 reference
Stephanie De Vos
1 reference
Ann Verheyen
1 reference
Kim Steegen
1 reference
Yvan Verlinden
1 reference
Graham P Allaway
1 reference
Lieven J Stuyver
1 reference
17 February 2009
1 reference
1 reference
Identifiers
1 reference